CVE-2011-3341

Description

Multiple off-by-one errors in order_cmd.cpp in OpenTTD before 1.1.3 allow remote attackers to cause a denial of service (daemon crash) or possibly execute arbitrary code via a crafted CMD_INSERT_ORDER command.

Category

7.5
CVSS
Severity: High
CVSS 2.0 •
EPSS 3.65% Top 15%
Vendor Advisory fedoraproject.org Vendor Advisory debian.org
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
http://lists.fedoraproject.org/pipermail/package-announce/2011-September/066128.html vendor advisory
http://secunia.com/advisories/46075 third party advisory
http://bugs.openttd.org/task/4745 patch
http://security.openttd.org/en/CVE-2011-3341
http://www.debian.org/security/2012/dsa-2386 vendor advisory
http://openwall.com/lists/oss-security/2011/09/02/4 mailing list patch
http://bugs.openttd.org/task/4745/getfile/7707/fixcmds.diff patch
http://www.securityfocus.com/bid/49439 vdb entry
http://openwall.com/lists/oss-security/2011/09/06/2 mailing list patch

Frequently Asked Questions

What is the severity of CVE-2011-3341?
CVE-2011-3341 has been scored as a high severity vulnerability.
How to fix CVE-2011-3341?
To fix CVE-2011-3341, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2011-3341 being actively exploited in the wild?
It is possible that CVE-2011-3341 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~4% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.